반응식
[CH3:1][C:2]1([CH3:14])[CH2:11][CH2:10][C:9]2[C:4](=[CH:5][CH:6]=[C:7]([CH:12]=O)[CH:8]=2)[O:3]1.[CH3:15][C:16]1[C:24]([Cl:25])=[CH:23][CH:22]=[C:21]2[C:17]=1[CH2:18][C:19](=[O:26])[NH:20]2>>[Cl:25][C:24]1[C:16]([CH3:15])=[C:17]2[C:21](=[CH:22][CH:23]=1)[NH:20][C:19](=[O:26])[C:18]2=[CH:12][C:7]1[CH:8]=[C:9]2[C:4](=[CH:5][CH:6]=1)[O:3][C:2]([CH3:14])([CH3:1])[CH2:11][CH2:10]2참가 물질
3
실험 절차
2,2-Dimethyl-6-formylchromane (commercially available) was condensed with 4-methyl-5-chloro-2-oxindole to give 0.3 g of 5-chloro-3-(2,2-dimethyl-chroman-6-ylmethylene)-4-methyl-1,3-dihydroindol-2-one as a yellow-orange solid.
출처 및 근거
- ORD 기록
- ord-7435161b1d0a4104bb4f28371075e7b6
- 출처 데이터셋
- uspto-grants-2005_02
- 특허 번호
- US06855730B2
연결된 노트
불러오는 중…